Nitnib 50mg Capsule is used in the treatment of the following condition:
- Renal cell carcinoma (RCC)
- Gastrointestinal stromal tumors (GIST)
- Pancreatic neuroendocrine tumors (PNET)
- Medullary thyroid cancer
- Certain kidney cancer
MRP | : |
|
Price | : | ₹1,390.00 |
You Save | : | ₹292.81 (17.4%) |
7 Capsule(s) In A Strip
Nitnib 50mg Capsule consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means that it works by blocking certain enzymes called tyrosine kinases that are involved in the growth and spread of cancer cells. This medication is used to treat gastrointestinal stromal tumors (GIST), rare cancer that can start anywhere in the gastrointestinal tract. This medication is also used to treat advanced kidney cancer, and pancreatic cancer called pancreatic neuroendocrine tumors (PNET). Cancer is a disorder in which abnormal cells grow in an uncontrolled manner. It is not recommended for people under 18.
Before taking Nitnib 50mg Capsule, it is important to discuss with the physician if you have blood conditions, heart problems, liver disorders, kidney problems, skin disorders, diabetes, seizures, or thyroid disorders. Also, inform if you have recently had surgery or are about to have surgery. Tell your doctor if you are hypertensive because this medication sometimes causes hypertension as a side effect. Avoid taking grapefruit in any form during the treatment with Nitnib 50mg Capsule. Check with your dentist if you have any problems in the mouth, such as mouth pain, swelling, or sores inside the mouth before starting treatment.
Nitnib 50mg Capsule is used in the treatment of the following condition:
The therapeutic benefits of Nitnib 50mg Capsule involve decelerating or halting the proliferation and dissemination of cancer cells within the body, consequently diminishing the size and quantity of tumors.
It functions by obstructing the action of particular proteins referred to as tyrosine kinases, which play a role in the signaling pathways that regulate cell growth and division.
By blocking these pathways, it can assist in preventing the growth and spread of cancer cells.
Inform your healthcare provider about all medications you are currently using, including prescription drugs, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Nitnib 50mg Capsule, possibly reducing its effectiveness and causing undesirable side effects.
• Take Nitnib 50 Capsule as directed by your physician, either with or without food.
• Generally, Nitnib 50 Capsule is administered once a day for a period of 28 days, succeeded by a 2-week pause. This regimen is repeated every 6 weeks, as per your doctor's guidance. Always adhere to your doctor's recommendations concerning dosage and duration.
• Swallow the capsule whole with a glass of water.
• Do not open, crush, or dissolve the Nitnib 50 Capsule.
Side effects refer to undesirable symptoms that arise from medications. While all drugs can lead to side effects, not everyone experiences them. The side effects associated with Nitnib 50mg Capsule include the following:
Serious:
Heart failure or heart attack
Elevated liver function tests.
Liver failure
Proteinuria
Acute kidney injury
Interstitial lung disease (inflammation of lung walls)
Pulmonary arterial hypertension
Gastrointestinal perforation or fistula
Haemorrhage (bleeding)
Hypothyroidism (low thyroid function)
Hypoglycemia (low blood sugar)
Common
Fatigue
Nausea and vomiting
Diarrhoea
Loss of appetite
Hand-foot syndrome
Skin discoloration or rash
High blood pressure
Headache
Hair loss
Changes in taste
Dry skin or itching
Nosebleeds
If you have been prescribed Nitnib 50mg Capsule, it is crucial to adhere to your healthcare provider's guidelines. During the course of treatment, refrain from consuming grapefruit or grapefruit juice, as they may elevate the medication levels in your bloodstream and potentially heighten the risk of side effects.
Utilize a dependable method of birth control while on this medication and for at least four weeks following your final dose.
This medication has the potential to cause severe side effects, making it essential to remain alert and well-informed about your treatment. Ensure that you report any symptoms or health changes, no matter how minor they may appear. With appropriate precautions and monitoring, it can serve as an effective treatment for specific types of cancer.
Molecule Name: Sunitinib
Therapeutic Class: Anticancer
Pharmacological Class: Tyrosine kinase inhibitor
Indications:
1. Renal cell carcinoma (RCC)
2. Gastrointestinal stromal tumors (GIST)
3. Pancreatic neuroendocrine tumors (PNET)
4. Medullary thyroid cancer
5. Certain kidney cancer
At Medfast, we’re dedicated to bringing you accurate, trustworthy, and expert-vetted health information. Our primary goal is to ensure you receive content that you can rely on.
It’s crucial to understand that everything on this website is for general information purposes only. This content is not a substitute for professional medical advice, diagnosis, or treatment. We can’t stress enough the importance of consulting with your own doctor. They are the only ones who can provide tailored advice for your specific health concerns or medication questions.
Please, never ignore or delay seeking professional medical advice because of something you’ve read here. Our fundamental mission is to support and enhance the doctor-patient relationship, not to replace it.
No related products found.
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
100% secure and trusted payment protection
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.